Complicated skin and soft tissue infections: literature review of evidence for and experience with daptomycin
Beth White, R Andrew SeatonBrownlee Center, Gartnavel General Hospital, Glasgow, ScotlandAbstract: Skin and soft tissue infections (SSTIs) are the second most common infection encountered in hospitals. Management decisions have become increasingly complex due to the prevalence of resistant pathogens...
Main Authors: | White B, Seaton RA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-05-01
|
Series: | Infection and Drug Resistance |
Online Access: | http://www.dovepress.com/complicated-skin-and-soft-tissue-infections-literature-review-of-evide-a7509 |
Similar Items
-
Daptomycin (Cubicin) in patients with complicated skin or soft-tissue infections
by: Viola Sacchi
Published: (2008-09-01) -
The Efficacy and Safety of High-dose Daptomycin in the Treatment of Complicated Skin and Soft Tissue Infections in Asians
by: Xiao-meng Dong, et al.
Published: (2020-06-01) -
Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections
by: Gonzalez-Ruiz A, et al.
Published: (2016-04-01) -
Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin
by: Eckmann Christian, et al.
Published: (2010-11-01) -
Efficacy and safety of daptomycin for skin and soft tissue infections: a systematic review with trial sequential analysis
by: Liu C, et al.
Published: (2016-09-01)